Daisuke Sanada

The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial

Ken Iseri, Masayuki Iyoda, Makoto Watanabe et al. · PLoS ONE · 2018 · 59 citations · Full text

Impact of Fibroblast Growth Factor 23 on Lipids and Atherosclerosis in Hemodialysis Patients

Eijin Ashikaga, Hirokazu Honda, Hiroki Suzuki et al. · Therapeutic Apheresis and Dialysis · 2010 · 34 citations

Hypertension, Immunology, Pathology +22

Ultrapure Dialysate Influences Serum Myeloperoxidase Levels and Lipid Metabolism

Hirokazu Honda, Hiroki Suzuki, Nozomu Hosaka et al. · Blood Purification · 2009 · 28 citations

High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients

Hirokazu Honda, Tetsuo Michihata, Kanji Shishido et al. · PLoS ONE · 2017 · 27 citations · Full text

MPO-ANCA crescentic glomerulonephritis complicated by membranous nephropathy: MPO demonstrated in epimembranous deposits

Kazuhiko Matsumoto, Hirokazu Honda, Takanori Shibata et al. · Clinical Kidney Journal · 2009 · 16 citations · Full text

Glomerular Disease, Vasculitis, Renal Pathology +24